Literature DB >> 16472803

Silencing of sigma-1 receptor induces cell death in human lens cells.

Lixin Wang1, George Duncan.   

Abstract

Sigma receptors have no known homology with other receptor systems, have no known natural ligands, but appear to play a critical role in a large diversity of cell functions. In the absence of a conventional pharmacology, siRNA technology provides a direct means of elucidating the major cell signaling pathways influenced by this receptor system. The non-transformed human lens cell line FHL124 was found to express the sigma-1 receptor (Sig-1R) and was employed for these studies. 72 h of transfection with either of the two siRNA directed against the sigma-1 receptor reduced messenger RNA and protein levels by over 70 and 60% respectively. Subsequent incubation for 96 h in culture medium (EMEM) supplemented with 5% serum gave a partial recovery of message, but there was no significant increase in protein. LDH leakage assays showed that significant cell death occurred during this time with an increased expression of caspase-3. Thrombin (10 nM) drives the growth of lens cells with a concomitant increase in ERK and Akt phosphorylation. These increases were inhibited in the cells where knockdown had occurred but not in cells exposed to scrambled siRNA. This study establishes a central role for Sig-1R in cell survival and death.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16472803     DOI: 10.1016/j.yexcr.2006.01.004

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  9 in total

1.  Antagonists show GTP-sensitive high-affinity binding to the sigma-1 receptor.

Authors:  J M Brimson; C A Brown; S T Safrany
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

Review 2.  Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders.

Authors:  Teruo Hayashi; Shang-Yi Tsai; Tomohisa Mori; Michiko Fujimoto; Tsung-Ping Su
Journal:  Expert Opin Ther Targets       Date:  2011-03-05       Impact factor: 6.902

3.  Late-onset inner retinal dysfunction in mice lacking sigma receptor 1 (σR1).

Authors:  Yonju Ha; Alan Saul; Amany Tawfik; Cory Williams; Kathryn Bollinger; Robert Smith; Masanori Tachikawa; Eric Zorrilla; Vadivel Ganapathy; Sylvia B Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-29       Impact factor: 4.799

4.  Sigma receptors [σRs]: biology in normal and diseased states.

Authors:  Colin G Rousseaux; Stephanie F Greene
Journal:  J Recept Signal Transduct Res       Date:  2015-06-09       Impact factor: 2.092

Review 5.  The pharmacology of sigma-1 receptors.

Authors:  Tangui Maurice; Tsung-Ping Su
Journal:  Pharmacol Ther       Date:  2009-07-18       Impact factor: 12.310

6.  Prevention of excitotoxicity in primary retinal ganglion cells by (+)-pentazocine, a sigma receptor-1 specific ligand.

Authors:  Ying Dun; Muthusamy Thangaraju; Puttur Prasad; Vadivel Ganapathy; Sylvia B Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-10       Impact factor: 4.799

7.  In vivo protection against retinal neurodegeneration by sigma receptor 1 ligand (+)-pentazocine.

Authors:  Sylvia B Smith; Jennifer Duplantier; Ying Dun; Barbara Mysona; Penny Roon; Pamela M Martin; Vadivel Ganapathy
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-05-09       Impact factor: 4.799

8.  Distal hereditary motor neuronopathy of the Jerash type is caused by a novel SIGMAR1 c.500A>T missense mutation.

Authors:  Antonis Ververis; Rana Dajani; Pantelitsa Koutsou; Ahmad Aloqaily; Carol Nelson-Williams; Erin Loring; Ala Arafat; Ammar Fayez Mubaidin; Khalid Horany; Mai B Bader; Yaqoub Al-Baho; Bushra Ali; Abdurrahman Muhtaseb; Tyrone DeSpenza; Abdelkarim A Al-Qudah; Lefkos T Middleton; Eleni Zamba-Papanicolaou; Richard Lifton; Kyproula Christodoulou
Journal:  J Med Genet       Date:  2019-09-11       Impact factor: 6.318

Review 9.  Sigma-1 Receptor in Retina: Neuroprotective Effects and Potential Mechanisms.

Authors:  Zifen Xu; Yushuang Lei; Huan Qin; Shiyao Zhang; Ping Li; Kai Yao
Journal:  Int J Mol Sci       Date:  2022-07-08       Impact factor: 6.208

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.